Please provide your email address to receive an email when new articles are posted on . Proton pump inhibitors with histamine 2 receptor antagonists reduced all-cause mortality in patients with ...
International Foundation for Gastrointestinal Disorders (IFFGD) launches #LetsTalkGERD, a social campaign raising awareness about Gastroesophageal Reflux Disease (GERD).
How Do I Take Voquezna? Voquezna is an oral tablet that is taken once daily for GERD or erosive esophagitis and twice daily for H. pylori. Voquezna can be taken with or without food. Your doctor will ...
The first treatment recommendation for patients with GERD is to make lifestyle changes (e.g., diet, scheduled eating times and sleeping positions). Proton pump inhibitor (PPI) medications are commonly ...
On May 5 at Digestive Disease Week a panel of nine gastroenterologists and digestive surgeons presented on radiofrequency therapy, or Stretta, as a treatment for gastroesophageal reflux disease. • ...
The FDA approved vonoprazan (Voquezna) as a daily treatment for heartburn associated with non-erosive gastroesophageal reflux disease (GERD) in adults. GERD is a condition in which acidic stomach ...
Cinclus Pharma Holding AB ( ($SE:CINPHA) ) has provided an update. Cinclus Pharma has sponsored a scientific conference abstract presented at the ...
telemedicine Researchers examined the risks for pneumonia and exacerbation of COPD after PPI treatment for GERD. The risk for symptom exacerbation reduced after PPI treatment for patients with GERD ...
Phathom Pharmaceuticals (PHAT) is a good biotech to keep an eye on in the coming months because it is gearing up to potentially receive an expanded FDA approval of its drug Voquenza as a daily ...
Milk may help with acid reflux in some people while worsening it in others. Test different types of milk to see how they ...
Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback